Sartorius (OTCMKTS:SARTF – Get Free Report) will likely be releasing its resultson Thursday, July 23rd. Analysts expect Sartorius to announce earnings of $1.56 per share and revenue of $1.0658 billion for the quarter.
Sartorius Stock Performance
OTCMKTS SARTF opened at $212.80 on Tuesday. The firm’s fifty day moving average price is $211.24 and its two-hundred day moving average price is $220.20. The stock has a market cap of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. Sartorius has a fifty-two week low of $181.58 and a fifty-two week high of $227.00.
About Sartorius
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.
Recommended Stories
- Five stocks we like better than Sartorius
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
